UCLA L-11: A Phase II Trial of Ivonescimab for Previously Treated Thymic Carcinoma
Latest Information Update: 07 Oct 2026
At a glance
- Drugs Ivonescimab (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- Acronyms UCLA L-11
Most Recent Events
- 29 Jul 2025 Status changed from not yet recruiting to recruiting.
- 28 May 2025 New trial record